RBC Capital Markets reiterated their positive stance on Alnylam Pharmaceuticals (NASDAQ:ALNY), maintaining an Outperform rating and a price target of $300.00. According to InvestingPro data, analyst ...

RBC Capital Markets adjusted its outlook on Edgewell Personal Care shares (NYSE:EPC), lowering the price target to $43.00 from the previous $48.00, while continuing to endorse the stock with an ...

FMC (NYSE:FMC) on Wednesday was downgraded to Sector Perform from a previous investment rating of Outperform by analysts at ...

Financial-services firm RBC Capital Markets downgraded Olin (OLN) to Sector Perform due to delayed demand recovery, but ...

J.M. Smucker Co. chief executive Mark Smucker leaned on close advisers when he made the decision to bolster the jelly and ...

In a report released on February 3, Kenneth Lee from RBC Capital maintained a Buy rating on Ares Management (ARES – Research Report), with a ...

But investors can still look forward to "solid" if more "moderate" returns in the year ahead, says RBC Capital Markets – and ... the December nonfarm payrolls report hit the tape, there was ...

In a report released today, Mandeep Jagpal from RBC Capital upgraded Schroders (SDR – Research Report) to a Buy, with a price target of p395.00. The company’s shares closed yesterday at p353.60.

We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished ...

Citi (C), JPMorgan Chase (JPM), Goldman Sachs (GS), and Wells Fargo (WFC) report on Wednesday, while Bank of America (BAC) and Morgan Stanley (MS) release results on Thursday. RBC Capital markets ...

U.S. President Donald Trump has jolted global markets with an earlier-than-expected and stringent implementation of tariffs ...